Inventor
WEXLER RUTH R
US27 patents
⚠️ This page may combine multiple inventors who share the name “WEXLER RUTH R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS7109339B2Sep 19, 2006
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
BRISTOL MYERS SQUIBB CO88 citations98
US9453018B2Sep 27, 2016
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO13 citations92
US6949550B2Sep 27, 2005
Substituted amino methyl factor Xa inhibitors
BRISTOL MYERS SQUIBB CO13 citations84
US11053247B2Jul 6, 2021
Pyrimidinones as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US10336754B2Jul 2, 2019
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US9777001B2Oct 3, 2017
Macrocycles with aromatic P2′ groups as factor xia inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US12428421B2Sep 30, 2025
Pyrimidinones as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US10273236B2Apr 30, 2019
Macrocyclic factor XIa inhibitors bearing heterocyclic groups
BRISTOL MYERS SQUIBB CO0 citations41
BRISTOL MYERS SQUIBB PHARMA CO
6 patentsUS6710058B2Mar 23, 2004
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO28 citations92
US6689770B2Feb 10, 2004
Aryl sulfonyls as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO29 citations92
US6602871B2Aug 5, 2003
Thrombin or factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO20 citations92
US6951872B2Oct 4, 2005
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO14 citations83
US6878710B2Apr 12, 2005
Bicyclic inhibitors of factor Xa
BRISTOL MYERS SQUIBB PHARMA CO2 citations52
US6790845B2Sep 14, 2004
Fused heterocyclic inhibitors of factor Xa
BRISTOL MYERS SQUIBB PHARMA CO1 citations52
DU PONT MERCK PHARMA
5 patentsUS5310748AMay 10, 1994
Imidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA45 citations91
US5166214ANov 24, 1992
Use of imidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA41 citations91
US5290801AMar 1, 1994
Benzimidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA56 citations89
US5478830ADec 26, 1995
Fused-ring heterocycles for the treatment of atherosclerosis
DU PONT MERCK PHARMA9 citations73
US5318984AJun 7, 1994
Imidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA15 citations72
DU PONT
4 patentsUS4632930ADec 30, 1986
Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
DU PONT44 citations92
US4576958AMar 18, 1986
Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives
DU PONT31 citations92
US5091390AFeb 25, 1992
Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogs
DU PONT36 citations91
US4868181ASep 19, 1989
1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
DU PONT3 citations60